191 related articles for article (PubMed ID: 7507413)
1. Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643.
Marsman DS; Popp JA
Carcinogenesis; 1994 Jan; 15(1):111-7. PubMed ID: 7507413
[TBL] [Abstract][Full Text] [Related]
2. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver.
Cattley RC; Popp JA
Cancer Res; 1989 Jun; 49(12):3246-51. PubMed ID: 2566380
[TBL] [Abstract][Full Text] [Related]
3. TGF alpha differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion.
Miller RT; Cattley RC; Marsman DS; Lyght O; Popp JA
Carcinogenesis; 1995 Jan; 16(1):77-82. PubMed ID: 7530605
[TBL] [Abstract][Full Text] [Related]
4. Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liver.
Cattley RC; Marsman DS; Popp JA
Carcinogenesis; 1991 Mar; 12(3):469-73. PubMed ID: 1849052
[TBL] [Abstract][Full Text] [Related]
5. Dietary glycine prevents the development of liver tumors caused by the peroxisome proliferator WY-14,643.
Rose ML; Cattley RC; Dunn C; Wong V; Li X; Thurman RG
Carcinogenesis; 1999 Nov; 20(11):2075-81. PubMed ID: 10545408
[TBL] [Abstract][Full Text] [Related]
6. The absence of gamma-glutamyl transpeptidase activity in putative preneoplastic lesions and in hepatocellular carcinomas induced in rats by the hypolipidemic peroxisome proliferator Wy-14,643.
Rao MS; Lalwani ND; Scarpelli DG; Reddy JK
Carcinogenesis; 1982; 3(10):1231-3. PubMed ID: 6129072
[TBL] [Abstract][Full Text] [Related]
7. Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver.
Moser GJ; Wolf DC; Goldsworthy TL
Toxicol Pathol; 1997; 25(3):275-83. PubMed ID: 9210259
[TBL] [Abstract][Full Text] [Related]
8. Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously.
Kraupp-Grasl B; Huber W; Taper H; Schulte-Hermann R
Cancer Res; 1991 Jan; 51(2):666-71. PubMed ID: 1985784
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis, mitosis and cyclophilin-40 expression in regressing peroxisome proliferator-induced adenomas.
Miller RT; Anderson SP; Corton JC; Cattley RC
Carcinogenesis; 2000 Apr; 21(4):647-52. PubMed ID: 10753199
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
Lake BG; Evans JG; Cunninghame ME; Price RJ
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):241-7. PubMed ID: 8013414
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent induction of carcinomas and glutathione S-transferase placental form negative eosinophilic foci in the rat liver by di(2-ethylhexyl)phthalate after diethylnitrosamine initiation.
Sano M; Hagiwara A; Tamano S; Hasegawa R; Imaida K; Ito N; Shirai T
J Toxicol Sci; 1999 Aug; 24(3):177-86. PubMed ID: 10478332
[TBL] [Abstract][Full Text] [Related]
12. Preneoplastic and neoplastic progression during hepatocarcinogenesis in mice injected with diethylnitrosamine in infancy.
Goldfarb S; Pugh TD; Koen H; He YZ
Environ Health Perspect; 1983 Apr; 50():149-61. PubMed ID: 6873010
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats.
Biegel LB; Hurtt ME; Frame SR; O'Connor JC; Cook JC
Toxicol Sci; 2001 Mar; 60(1):44-55. PubMed ID: 11222872
[TBL] [Abstract][Full Text] [Related]
14. A sequential study of methapyrilene hydrochloride-induced liver carcinogenesis in male F344 rats.
Ohshima M; Ward JM; Brennan LM; Creasia DA
J Natl Cancer Inst; 1984 Mar; 72(3):759-68. PubMed ID: 6583458
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats.
Hayashi F; Tamura H; Yamada J; Kasai H; Suga T
Carcinogenesis; 1994 Oct; 15(10):2215-9. PubMed ID: 7955056
[TBL] [Abstract][Full Text] [Related]
16. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
Marsman DS; Cattley RC; Conway JG; Popp JA
Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084
[TBL] [Abstract][Full Text] [Related]
17. Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet.
Lalwani ND; Reddy MK; Qureshi SA; Reddy JK
Carcinogenesis; 1981; 2(7):645-50. PubMed ID: 7273344
[TBL] [Abstract][Full Text] [Related]
18. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.
Peters JM; Cattley RC; Gonzalez FJ
Carcinogenesis; 1997 Nov; 18(11):2029-33. PubMed ID: 9395198
[TBL] [Abstract][Full Text] [Related]
19. Initiator-specific promotion of hepatocarcinogenesis by WY-14,643 and clofibrate.
Cattley RC; Kato M; Popp JA; Teets VJ; Voss KS
Carcinogenesis; 1994 Aug; 15(8):1763-6. PubMed ID: 8055661
[TBL] [Abstract][Full Text] [Related]
20. Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid.
Marsman DS; Goldsworthy TL; Popp JA
Carcinogenesis; 1992 Jun; 13(6):1011-7. PubMed ID: 1600604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
